Yes, we make every attempt to offer exempt preparations as soon as possible, but exempt preparations must be approved by the DEA, and the process requires several steps. When the DEA identifies a new controlled substance, Cayman must apply for the applicable drug code to be added to our DEA manufacturing registration. The DEA has up to 90 days to perform an audit of our application and once completed, DEA headquarters will review and post for an additional 60-day public comment period. Once the drug code is approved, Cayman can prepare an application for exempt preparations. Depending on the length and complexity of the application, the DEA review and approval process may range from 3 to 12 months to complete. Some exempt preparations will have “exempt preparation” in the item name, while others will have “CRM” in the name. It is important to note that not all CRM items are exempt preparations.